Clinical Trial Update: Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients [Phase 2]

View source ↗

Summary

Phase 2b trial evaluating AR882 for gout shows completed status; provides data on efficacy and safety in gout patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis Gouty
• Gout
• Gout Chronic
• Hyperuricemia

Drugs mentioned

• AR882

Snippet

Sponsor: Arthrosi Therapeutics | Conditions: Gout, Arthritis, Gouty | Phase 2 | Status: COMPLETED